News & Events
Read our recent press releases and follow Vascudyne’s newest advancements
July 1, 2021
Vascudyne Announces Successful First Human Use of TRUE Vascular Graft for Hemodialysis Access
Vascudyne announces the successful first-in-human use of its hemodialysis access conduits in end-stage renal disease patients. The clinical procedures were performed by Adrian Ebner, MD, Director of Endovascular and Cardiovascular Surgery at Sanatorio Italiano in Asuncion, Paraguay, and his skilled team.
Most patients with end-stage renal disease rely on hemodialysis and need a conduit that connects the patient’s bloodstream to the hemodialysis machine. Vascudyne’s 100% biological tissue technology has the potential of addressing current graft issues such as infection, intimal hyperplasia, and thrombosis.
Early clinical feedback holds promise for a major impact on hemodialysis patient care by reducing dialysis care costs and improving quality of life for patients.
Address
Social Media
These are investigational uses that have not been approved by any health authority. Safety and efficacy have not been established and there is no guarantee that pipeline products or investigational uses will receive approval from health authorities.
Copyright 2025 | Vascudyne, Inc.
